{"id":1929,"date":"2024-02-29T21:24:00","date_gmt":"2024-02-29T21:24:00","guid":{"rendered":"https:\/\/www.bcchr.ca\/foodallergy\/?p=1929"},"modified":"2026-11-04T21:39:09","modified_gmt":"2026-11-04T21:39:09","slug":"safer-treatment-path-high-risk-children-overcome-food-allergies","status":"publish","type":"post","link":"https:\/\/www.bcchr.ca\/foodallergy\/2024\/02\/29\/safer-treatment-path-high-risk-children-overcome-food-allergies\/","title":{"rendered":"A safer treatment path for high-risk children to overcome food allergies"},"content":{"rendered":"<p class=\"fndry-paragraph\">New research from BC Children\u2019s Hospital Research Institute and the University of British Columbia (UBC) reveals a safe path to overcoming food allergies for older children or building resistance for those who can\u2019t risk consuming allergens.<\/p>\n\n<p class=\"fndry-paragraph\">It\u2019s called sublingual immunotherapy (SLIT), and it involves placing small amounts of food allergens under the tongue.<\/p>\n\n<p class=\"fndry-paragraph\">A study conducted by Dr.\u00a0<a href=\"https:\/\/www.bcchr.ca\/research\/find-a-researcher\/edmond-s-chan\/\">Edmond Chan<\/a>, a pediatric allergist at BC Children\u2019s and UBC clinical professor, and his team found SLIT to be as safe and effective for high-risk older children and adolescents as oral immunotherapy is for preschoolers.<\/p>\n\n<div  class=\"fndry-container fndry-responsive-bg fndry-responsive-border fndry-pt--3 fndry-pb--3 fndry-pr--md-1 fndry-pl--md-1 fndry-pt--sm-0 fndry-pb--sm-0 fndry-mt--sm-3 fndry-mb--sm-3\">\n\t<div class=\"fndry-row\">\n\t<div  class=\"fndry-col fndry-responsive-bg fndry-col--12 fndry-col--sm-12 fndry-col--md-12 fndry-pl--sm-0\">\n\t<div  class=\"fndry-container fndry-responsive-bg fndry-responsive-border fndry-pt--3 fndry-pr--3 fndry-pb--3 fndry-pl--3 fndry-pt--sm-2 fndry-pr--sm-2 fndry-pb--sm-2 fndry-pl--sm-2\" style=\"--fndry-bg:var(--fndry-color-light)\">\n\t<figure  class=\"fndry-quote fndry-quote--left\">\n\t<blockquote class=\"fndry-quote__quote\">\n\t\t<p class=\"fndry-text-intro22\">Our work confirms the safety and effectiveness of SLIT for older children and adolescents with multiple food allergies at higher risk of severe reaction.<\/p>\t<\/blockquote>\n\t<figcaption  class=\"fndry-quote__citation\">\n\t\t&#8211; Dr. Edmond Chan\t<\/figcaption>\n<\/figure><\/div>\n<\/div>\n<\/div><\/div>\n\n\n<div  class=\"fndry-container fndry-responsive-bg fndry-responsive-border fndry-pt--0 fndry-pb--0 fndry-pr--md-1 fndry-pl--md-1 fndry-pt--sm-0 fndry-pb--sm-0 fndry-mt--sm-3 fndry-mb--sm-3\">\n\t<div class=\"fndry-row\">\n\t<div  class=\"fndry-col fndry-responsive-bg fndry-col--12 fndry-col--sm-12 fndry-col--md-12 fndry-pb--2 fndry-pt--2 fndry-pl--sm-0\">\n\t<p class=\"fndry-paragraph\">\u201cOur work confirms the safety and effectiveness of SLIT for older children and adolescents with multiple food allergies at higher risk of severe reaction,\u201d says Dr. Chan. \u201cThese are patients for whom oral immunotherapy would typically be denied because it\u2019s felt to be too risky, so this could be the best approach for that population.\u201d<\/p><p class=\"fndry-paragraph\"><a href=\"https:\/\/www.bcchr.ca\/news\/oral-immunotherapy-safe-for-preschool-aged-children-with-peanut-allergies\/\">Previously published research<\/a>&nbsp;from Dr. Chan\u2019s team has shown that preschool oral immunotherapy is safe and effective in the real world. The protocol involves a \u201cbuild-up phase\u201d of several months, when patients visit a clinic every two weeks to ingest a higher dose of an allergen under medical supervision before continuing the same daily dose between visits. When they reach a certain dose \u2014 usually around 300 mg of protein \u2014 they enter a \u201cmaintenance phase\u201d during which they take that target daily dose at home. After a year of maintenance doses, approximately four out of five patients are able to pass an oral challenge test in which they tolerate a much higher dose of 4,000 mg of protein.<\/p><p class=\"fndry-paragraph\">However, the build-up phase is risky for older children and those with a history of severe reactions. Dr. Chan\u2019s group has been looking for a safer way to get this at-risk group of patients to the maintenance phase.<\/p><p class=\"fndry-paragraph\">They recruited about 180 such patients between the ages of four and 18, most with multiple food allergies. The SLIT protocol (started when COVID-19 pandemic restrictions were in place) required patients to have virtually supervised appointments three to five times over several months to build up to a small dose \u2014 in most cases, just two mg of protein \u2014 which is absorbed through the membranes under the tongue rather than swallowed and ingested.<\/p><\/div>\n<\/div><\/div>\n\n\n<div  class=\"fndry-container fndry-responsive-bg fndry-responsive-border fndry-pb--0 fndry-pt--0 fndry-pr--md-1 fndry-pl--md-1 fndry-pt--sm-0 fndry-pb--sm-0 fndry-mt--sm-3 fndry-mb--sm-3\">\n\t<div class=\"fndry-row\">\n\t<div  class=\"fndry-col fndry-responsive-bg fndry-col--12 fndry-col--sm-12 fndry-col--md-12 fndry-d--flex fndry-flex--col fndry-align--start fndry-justify--center\">\n\t<figure  class=\"fndry-image\" style=\"--imageWidth:100%;--img-height-all:520px\" aria-labelledby=\"img-1931\">\n\t<img loading=\"lazy\" decoding=\"async\" width=\"780\" height=\"520\" src=\"https:\/\/www.bcchr.ca\/foodallergy\/files\/2026\/08\/edmond-chan-dario-filippelli.jpg\" class=\"fndry-image__img\" aria-hidden=\"true\" role=\"presentation\" style=\"--borderRadius:0px;--objectFit:cover;--imagePosX:50%;--imagePosY:50%\" srcset=\"https:\/\/www.bcchr.ca\/foodallergy\/files\/2026\/08\/edmond-chan-dario-filippelli.jpg 900w, https:\/\/www.bcchr.ca\/foodallergy\/files\/2026\/08\/edmond-chan-dario-filippelli-300x200.jpg 300w, https:\/\/www.bcchr.ca\/foodallergy\/files\/2026\/08\/edmond-chan-dario-filippelli-768x512.jpg 768w\" sizes=\"(max-width: 780px) 100vw, 780px\" \/><\/figure>\n<div  class=\"fndry-container fndry-responsive-bg fndry-responsive-border fndry-pt--2 fndry-pl--2 fndry-pr--2\" style=\"--fndry-bg:var(--fndry-color-light)\">\n\t<p class=\"fndry-paragraph\">Dr. Edmond Chan (left) poses with study participant Dario Filippelli, who was all smiles after passing his oral food challenge. (Photo courtesy of Dr. Edmond Chan)<\/p><\/div>\n<\/div>\n<\/div><\/div>\n\n\n<div  class=\"fndry-container fndry-responsive-bg fndry-responsive-border fndry-pt--3 fndry-pb--3 fndry-pr--md-1 fndry-pl--md-1 fndry-pt--sm-0 fndry-pb--sm-0 fndry-mt--sm-3 fndry-mb--sm-3\">\n\t<div class=\"fndry-row\">\n\t<div  class=\"fndry-col fndry-responsive-bg fndry-col--12 fndry-col--sm-12 fndry-col--md-12 fndry-pl--sm-0\">\n\t<p class=\"fndry-paragraph\">The patients\u2019 caregivers learned how to mix and administer these doses at home using novel recipes based on products you can buy at the grocery store, developed with the team\u2019s research dietitian. A wide variety of allergens were treated, including peanut, other legumes, tree nuts, sesame, other seeds, egg, cow\u2019s milk, fish, wheat, shrimp, and other allergens. Patients took these doses daily for one to two years.<\/p><p class=\"fndry-paragraph\">\u201cIt takes up to twice as long as oral immunotherapy, but we wouldn\u2019t have had it any other way because we needed the superior safety of SLIT for these older kids that are felt to be more severe,\u201d says Dr. Chan.<\/p><p class=\"fndry-paragraph\">While most patients had mild symptoms during the build-up phase, none had severe reactions during either the build-up or maintenance stages. Seventy per cent of those tested at the end of the protocol could tolerate 300 mg of their allergen \u2014 a success rate nearly as high as that for oral immunotherapy.<\/p><p class=\"fndry-paragraph\">The results were encouraging for a therapy that any family can undertake at home with guidance from professionals.<\/p><p class=\"fndry-paragraph\">\u201cBesides safety considerations in older children, allergists are often quite burdened by the oral immunotherapy build-up phase, where a patient may require 11 or more visits to the clinic. They just don\u2019t feel they have the capacity to offer that many visits in their office,\u201d says Dr. Chan. \u201cIn our clinic, we are starting to do more home-based approaches because the demand for medical appointments that would allow supervision far outstrips the supply. We are trying to develop an approach, based on data, that matches a patient\u2019s risk level with the appropriate amount of supervision. Our SLIT data suggests that home-based SLIT build-up is safe.\u201d<\/p><p class=\"fndry-paragraph\">Ultimately, the trial highlights an alternative that allergists should now consider for patients who cannot safely undertake oral immunotherapy. The trade-off for greater safety is simply a longer timeline, but it comes with the benefit of keeping clinics free for those who need them most.<\/p><p class=\"fndry-paragraph\">Credit:&nbsp;<a href=\"https:\/\/news.ubc.ca\/2024\/02\/29\/safer-treatment-for-food-allergies\/\" target=\"_blank\" rel=\"noreferrer noopener\">UBC Media Relations news release<\/a><\/p><\/div>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>New research from BC Children\u2019s Hospital Research Institute and UBC reveals a safe path to overcoming food allergies for older children or building resistance for those who can\u2019t risk consuming allergens. It\u2019s called sublingual immunotherapy (SLIT).<\/p>\n","protected":false},"author":20,"featured_media":1930,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"no","_lmt_disable":"","inline_featured_image":false,"footnotes":"","fndry_alternate_title":""},"categories":[10],"tags":[],"class_list":["post-1929","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"modified_by":"Andrea Sakamoto","_links":{"self":[{"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/posts\/1929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/comments?post=1929"}],"version-history":[{"count":10,"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/posts\/1929\/revisions"}],"predecessor-version":[{"id":2505,"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/posts\/1929\/revisions\/2505"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/media\/1930"}],"wp:attachment":[{"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/media?parent=1929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/categories?post=1929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/tags?post=1929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}